[{"path":[]},{"path":"https://ggrlab.github.io/dataMelanoma/CODE_OF_CONDUCT.html","id":"our-pledge","dir":"","previous_headings":"","what":"Our Pledge","title":"Contributor Covenant Code of Conduct","text":"members, contributors, leaders pledge make participation community harassment-free experience everyone, regardless age, body size, visible invisible disability, ethnicity, sex characteristics, gender identity expression, level experience, education, socio-economic status, nationality, personal appearance, race, caste, color, religion, sexual identity orientation. pledge act interact ways contribute open, welcoming, diverse, inclusive, healthy community.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CODE_OF_CONDUCT.html","id":"our-standards","dir":"","previous_headings":"","what":"Our Standards","title":"Contributor Covenant Code of Conduct","text":"Examples behavior contributes positive environment community include: Demonstrating empathy kindness toward people respectful differing opinions, viewpoints, experiences Giving gracefully accepting constructive feedback Accepting responsibility apologizing affected mistakes, learning experience Focusing best just us individuals, overall community Examples unacceptable behavior include: use sexualized language imagery, sexual attention advances kind Trolling, insulting derogatory comments, personal political attacks Public private harassment Publishing others’ private information, physical email address, without explicit permission conduct reasonably considered inappropriate professional setting","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CODE_OF_CONDUCT.html","id":"enforcement-responsibilities","dir":"","previous_headings":"","what":"Enforcement Responsibilities","title":"Contributor Covenant Code of Conduct","text":"Community leaders responsible clarifying enforcing standards acceptable behavior take appropriate fair corrective action response behavior deem inappropriate, threatening, offensive, harmful. Community leaders right responsibility remove, edit, reject comments, commits, code, wiki edits, issues, contributions aligned Code Conduct, communicate reasons moderation decisions appropriate.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CODE_OF_CONDUCT.html","id":"scope","dir":"","previous_headings":"","what":"Scope","title":"Contributor Covenant Code of Conduct","text":"Code Conduct applies within community spaces, also applies individual officially representing community public spaces. Examples representing community include using official e-mail address, posting via official social media account, acting appointed representative online offline event.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CODE_OF_CONDUCT.html","id":"enforcement","dir":"","previous_headings":"","what":"Enforcement","title":"Contributor Covenant Code of Conduct","text":"Instances abusive, harassing, otherwise unacceptable behavior may reported community leaders responsible enforcement codeofconduct@posit.co. complaints reviewed investigated promptly fairly. community leaders obligated respect privacy security reporter incident.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CODE_OF_CONDUCT.html","id":"enforcement-guidelines","dir":"","previous_headings":"","what":"Enforcement Guidelines","title":"Contributor Covenant Code of Conduct","text":"Community leaders follow Community Impact Guidelines determining consequences action deem violation Code Conduct:","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CODE_OF_CONDUCT.html","id":"id_1-correction","dir":"","previous_headings":"Enforcement Guidelines","what":"1. Correction","title":"Contributor Covenant Code of Conduct","text":"Community Impact: Use inappropriate language behavior deemed unprofessional unwelcome community. Consequence: private, written warning community leaders, providing clarity around nature violation explanation behavior inappropriate. public apology may requested.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CODE_OF_CONDUCT.html","id":"id_2-warning","dir":"","previous_headings":"Enforcement Guidelines","what":"2. Warning","title":"Contributor Covenant Code of Conduct","text":"Community Impact: violation single incident series actions. Consequence: warning consequences continued behavior. interaction people involved, including unsolicited interaction enforcing Code Conduct, specified period time. includes avoiding interactions community spaces well external channels like social media. Violating terms may lead temporary permanent ban.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CODE_OF_CONDUCT.html","id":"id_3-temporary-ban","dir":"","previous_headings":"Enforcement Guidelines","what":"3. Temporary Ban","title":"Contributor Covenant Code of Conduct","text":"Community Impact: serious violation community standards, including sustained inappropriate behavior. Consequence: temporary ban sort interaction public communication community specified period time. public private interaction people involved, including unsolicited interaction enforcing Code Conduct, allowed period. Violating terms may lead permanent ban.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CODE_OF_CONDUCT.html","id":"id_4-permanent-ban","dir":"","previous_headings":"Enforcement Guidelines","what":"4. Permanent Ban","title":"Contributor Covenant Code of Conduct","text":"Community Impact: Demonstrating pattern violation community standards, including sustained inappropriate behavior, harassment individual, aggression toward disparagement classes individuals. Consequence: permanent ban sort public interaction within community.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CODE_OF_CONDUCT.html","id":"attribution","dir":"","previous_headings":"","what":"Attribution","title":"Contributor Covenant Code of Conduct","text":"Code Conduct adapted Contributor Covenant, version 2.1, available https://www.contributor-covenant.org/version/2/1/code_of_conduct.html. Community Impact Guidelines inspired [Mozilla’s code conduct enforcement ladder][https://github.com/mozilla/inclusion]. answers common questions code conduct, see FAQ https://www.contributor-covenant.org/faq. Translations available https://www.contributor-covenant.org/translations.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CONTRIBUTING.html","id":null,"dir":"","previous_headings":"","what":"Contributing to dataMelanoma","title":"Contributing to dataMelanoma","text":"outlines propose change dataMelanoma. detailed discussion contributing tidyverse packages, please see development contributing guide code review principles.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CONTRIBUTING.html","id":"fixing-typos","dir":"","previous_headings":"","what":"Fixing typos","title":"Contributing to dataMelanoma","text":"can fix typos, spelling mistakes, grammatical errors documentation directly using GitHub web interface, long changes made source file. generally means ’ll need edit roxygen2 comments .R, .Rd file. can find .R file generates .Rd reading comment first line.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CONTRIBUTING.html","id":"bigger-changes","dir":"","previous_headings":"","what":"Bigger changes","title":"Contributing to dataMelanoma","text":"want make bigger change, ’s good idea first file issue make sure someone team agrees ’s needed. ’ve found bug, please file issue illustrates bug minimal reprex (also help write unit test, needed). See guide create great issue advice.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CONTRIBUTING.html","id":"pull-request-process","dir":"","previous_headings":"Bigger changes","what":"Pull request process","title":"Contributing to dataMelanoma","text":"Fork package clone onto computer. haven’t done , recommend using usethis::create_from_github(\"ggrlab/dataMelanoma\", fork = TRUE). Install development dependencies devtools::install_dev_deps(), make sure package passes R CMD check running devtools::check(). R CMD check doesn’t pass cleanly, ’s good idea ask help continuing. Create Git branch pull request (PR). recommend using usethis::pr_init(\"brief-description--change\"). Make changes, commit git, create PR running usethis::pr_push(), following prompts browser. title PR briefly describe change. body PR contain Fixes #issue-number. user-facing changes, add bullet top NEWS.md (.e. just first header). Follow style described https://style.tidyverse.org/news.html.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CONTRIBUTING.html","id":"code-style","dir":"","previous_headings":"Bigger changes","what":"Code style","title":"Contributing to dataMelanoma","text":"New code follow tidyverse style guide. can use styler package apply styles, please don’t restyle code nothing PR. use roxygen2, Markdown syntax, documentation. use testthat unit tests. Contributions test cases included easier accept.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/CONTRIBUTING.html","id":"code-of-conduct","dir":"","previous_headings":"","what":"Code of Conduct","title":"Contributing to dataMelanoma","text":"Please note dataMelanoma project released Contributor Code Conduct. contributing project agree abide terms.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/LICENSE.html","id":null,"dir":"","previous_headings":"","what":"MIT License","title":"MIT License","text":"Copyright (c) 2023 dataMelanoma authors Permission hereby granted, free charge, person obtaining copy software associated documentation files (“Software”), deal Software without restriction, including without limitation rights use, copy, modify, merge, publish, distribute, sublicense, /sell copies Software, permit persons Software furnished , subject following conditions: copyright notice permission notice shall included copies substantial portions Software. SOFTWARE PROVIDED “”, WITHOUT WARRANTY KIND, EXPRESS IMPLIED, INCLUDING LIMITED WARRANTIES MERCHANTABILITY, FITNESS PARTICULAR PURPOSE NONINFRINGEMENT. EVENT SHALL AUTHORS COPYRIGHT HOLDERS LIABLE CLAIM, DAMAGES LIABILITY, WHETHER ACTION CONTRACT, TORT OTHERWISE, ARISING , CONNECTION SOFTWARE USE DEALINGS SOFTWARE.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/SUPPORT.html","id":null,"dir":"","previous_headings":"","what":"Getting help with dataMelanoma","title":"Getting help with dataMelanoma","text":"Thanks using dataMelanoma! filing issue, places explore pieces put together make process smooth possible.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/SUPPORT.html","id":"make-a-reprex","dir":"","previous_headings":"","what":"Make a reprex","title":"Getting help with dataMelanoma","text":"Start making minimal reproducible example using reprex package. haven’t heard used reprex , ’re treat! Seriously, reprex make R-question-asking endeavors easier (pretty insane ROI five ten minutes ’ll take learn ’s ). additional reprex pointers, check Get help! section tidyverse site.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/SUPPORT.html","id":"where-to-ask","dir":"","previous_headings":"","what":"Where to ask?","title":"Getting help with dataMelanoma","text":"Armed reprex, next step figure ask. ’s question: start community.rstudio.com, /StackOverflow. people answer questions. ’s bug: ’re right place, file issue. ’re sure: let community help figure ! problem bug feature request, can easily return report . opening new issue, sure search issues pull requests make sure bug hasn’t reported /already fixed development version. default, search pre-populated :issue :open. can edit qualifiers (e.g. :pr, :closed) needed. example, ’d simply remove :open search issues repo, open closed.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/SUPPORT.html","id":"what-happens-next","dir":"","previous_headings":"","what":"What happens next?","title":"Getting help with dataMelanoma","text":"efficient possible, development tidyverse packages tends bursty, shouldn’t worry don’t get immediate response. Typically don’t look repo sufficient quantity issues accumulates, ’s burst intense activity focus efforts. makes development efficient avoids expensive context switching problems, cost taking longer get back . process makes good reprex particularly important might multiple months initial report start working . can’t reproduce bug, can’t fix !","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Gunther Glehr. Author, maintainer.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Glehr G (2023). dataMelanoma: data source melanoma data. https://github.com/ggrlab/dataMelanoma, https://ggrlab.github.io/dataMelanoma/.","code":"@Manual{,   title = {dataMelanoma: A data source for melanoma data},   author = {Gunther Glehr},   year = {2023},   note = {https://github.com/ggrlab/dataMelanoma, https://ggrlab.github.io/dataMelanoma/}, }"},{"path":"https://ggrlab.github.io/dataMelanoma/reference/create_data_project.html","id":null,"dir":"Reference","previous_headings":"","what":"Create a data project stump — create_data_project","title":"Create a data project stump — create_data_project","text":"Creates directories first files data project","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/create_data_project.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Create a data project stump — create_data_project","text":"","code":"create_data_project(name)"},{"path":"https://ggrlab.github.io/dataMelanoma/reference/create_data_project.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Create a data project stump — create_data_project","text":"name name project","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/dataMelanoma-package.html","id":null,"dir":"Reference","previous_headings":"","what":"dataMelanoma: A data source for melanoma data — dataMelanoma-package","title":"dataMelanoma: A data source for melanoma data — dataMelanoma-package","text":"package provides various melanoma datasets. gives access code used harvest/preprocess data, well data . processed data stored git-lfs long possible. github's quota reached, might switch zenodo.","code":""},{"path":[]},{"path":"https://ggrlab.github.io/dataMelanoma/reference/dataMelanoma-package.html","id":"author","dir":"Reference","previous_headings":"","what":"Author","title":"dataMelanoma: A data source for melanoma data — dataMelanoma-package","text":"Maintainer: Gunther Glehr gunthergl@gmx.net (ORCID)","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/lozano2022_pheno_cytof.html","id":null,"dir":"Reference","previous_headings":"","what":"Phenotypic data from Lozano et al. — lozano2022_pheno_cytof","title":"Phenotypic data from Lozano et al. — lozano2022_pheno_cytof","text":"Phenotypic data Lozano et al.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/lozano2022_pheno_cytof.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Phenotypic data from Lozano et al. — lozano2022_pheno_cytof","text":"","code":"lozano2022_pheno_cytof"},{"path":"https://ggrlab.github.io/dataMelanoma/reference/lozano2022_pheno_cytof.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Phenotypic data from Lozano et al. — lozano2022_pheno_cytof","text":"data frame 18 rows (samples) 39 columns (features). first 18 columns phenotypic features, remaining 20 columns CyTOF features. CyTOF features prefixed cytof_ values proportions cells sample. populations normalized relative total evaluable PBMCs,","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/lozano2022_pheno_cytof.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Phenotypic data from Lozano et al. — lozano2022_pheno_cytof","text":"Lozano, .X., Chaudhuri, .., Nene, . et al. T cell characteristics associated toxicity immune checkpoint blockade patients melanoma. Nat Med 28, 353–362 (2022). https://doi.org/10.1038/s41591-021-01623-z","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/sim_intraassay_sim00_pure_estimate.html","id":null,"dir":"Reference","previous_headings":"","what":"Simulated data from intraassay data — sim_intraassay_sim00_pure_estimate","title":"Simulated data from intraassay data — sim_intraassay_sim00_pure_estimate","text":"Simulated data intraassay data, 100 samples. Created within /home/gugl/clonedgit/paper/2023-Glehr_rROC_code","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/sim_intraassay_sim00_pure_estimate.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Simulated data from intraassay data — sim_intraassay_sim00_pure_estimate","text":"","code":"sim_intraassay_sim00_pure_estimate"},{"path":"https://ggrlab.github.io/dataMelanoma/reference/sim_intraassay_sim00_pure_estimate.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Simulated data from intraassay data — sim_intraassay_sim00_pure_estimate","text":"data frame 100 rows (samples) 143 columns (features). 143 columns, 141 cell population counts features, \"V1\" (column 1) sample name \"fake_labels\" randomly sampled group labels.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/sim_intraassay_sim00_pure_estimate.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Simulated data from intraassay data — sim_intraassay_sim00_pure_estimate","text":"https://git.uni-regensburg.de/paper/2023-Glehr_rROC_code.git","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/zhang2022.html","id":null,"dir":"Reference","previous_headings":"","what":"Zhang2022 bulk data — zhang2022","title":"Zhang2022 bulk data — zhang2022","text":"Data Zhang et al. 2022 combines data 10 immunotherapy cohorts. Especially used following cohorts training validation sets:   separate, independent testing cohort comes following publications:   Find extensive description data original publications Zhang2022, supplementary table S3. https://static-content.springer.com/esm/art%3A10.1186%2Fs13073-022-01050-w/MediaObjects/13073_2022_1050_MOESM1_ESM.pdf Following analysis supplied figshare https://figshare.com/articles/online_resource/Integrated_analysis_of_single-cell_and_bulk_RNA_sequencing_data_reveals_a_pan-cancer_stemness_signature_predicting_immunotherapy_response/17654633 training data established using \"ios.Rdata\", data 10 cohorts combined. authors give information data gathered exactly. data preprocessed sva::ComBat()  (default parameters) remove batch effects. Data first 5 described cohorts split randomly training (80%, zhang2022_training) validation (20%, zhang2022_validation) sets. remaining 5 cohorts used independent testing set (zhang2022_testing). Apart gene expression data, established Stem.Sig gene signature consists selected genes (coefficients) \"correlated CytoTRACE scores\" 34 scRNA-seq datasets.","code":"- Braun 2020  Braun DA, Hou Y, Bakouny Z, Ficial M, Sant’ Angelo M, Forman J, et al. Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma. Nat Med. 2020;26:909–18. https://doi.org/10.1038/s41591-020-0839-y  - Mariathasan 2018 Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554:544–8. https://doi.org/10.1038/nature25501  - Liu 2019  Liu D, Schilling B, Liu D, Sucker A, Livingstone E, Jerby-amon L, et al. Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nat Med. 2019;25. https://doi.org/10.1038/s41591-019-0654-5  - Gide 2019 Gide TN, Quek C, Menzies AM, Tasker AT, Shang P, Holst J, et al. Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy. Cancer Cell. 2019;35:238-255.e6. https://doi.org/10.1016/j.ccell.2019.01.003  - Riaz 2017 Riaz N, Havel JJ, Makarov V, Desrichard A, Urba WJ, Sims JS, et al. Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. Cell. 2017;171:934-949.e16. https://doi.org/10.1016/j.cell.2017.09.028 - Zhao 2019 Zhao J, Chen AX, Gartrell RD, Silverman AM, Aparicio L, Chu T, et al. Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma. Nat Med. 2019;25:462–9. https://doi.org/10.1038/s41591-019-0349-y  - Snyder 2017 Snyder A, Nathanson T, Funt SA, Ahuja A, Buros Novik J, Hellmann MD, et al. Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis. Minna JD, editor. PLOS Med. 2017;14:e1002309. https://doi.org/10.1371/journal.pmed.1002309  - Hugo 2016  Hugo W, Zaretsky JM, Sun L, Song C, Moreno BH, Hu-Lieskovan S, et al. Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma. Cell. 2016;165:35–44. https://doi.org/10.1016/j.cell.2016.02.065  - Van 2015 Van Allen EM, Miao D, Schilling B, Shukla SA, Blank C, Zimmer L, et al. Erratum for the Report “Genomic correlates of response to CTLA-4 blockade in metastatic melanoma” by E. M. Van Allen, D. Miao, B. Schilling, S. A. Shukla, C. Blank, L. Zimmer, A. Sucker, U. Hillen, M. H. Geukes Foppen, S. M. Goldinger, J. Utikal, J. C. Ha. Science. 2016;352:aaf8264–aaf8264. https://doi.org/10.1126/science.aaf8264  - Kim 2018 Kim ST, Cristescu R, Bass AJ, Kim K-M, Odegaard JI, Kim K, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018;24:1449–58. https://doi.org/10.1038/s41591-018-0101-z"},{"path":"https://ggrlab.github.io/dataMelanoma/reference/zhang2022.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Zhang2022 bulk data — zhang2022","text":"","code":"zhang2022()"},{"path":"https://ggrlab.github.io/dataMelanoma/reference/zhang2022.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Zhang2022 bulk data — zhang2022","text":"Zhang, Z., Wang, ZX., Chen, YX. et al. Integrated analysis single-cell bulk RNA sequencing data reveals pan-cancer stemness signature predicting immunotherapy response. Genome Med 14, 45 (2022). https://doi.org/10.1186/s13073-022-01050-w","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/zhang2022_Stem.Sig.html","id":null,"dir":"Reference","previous_headings":"","what":"Zhang 2022 Stem.Sig gene signature — zhang2022_Stem.Sig","title":"Zhang 2022 Stem.Sig gene signature — zhang2022_Stem.Sig","text":"Stem.Sig gene signature Zhang2022, see also zhang2022.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/zhang2022_Stem.Sig.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Zhang 2022 Stem.Sig gene signature — zhang2022_Stem.Sig","text":"","code":"zhang2022_Stem.Sig"},{"path":"https://ggrlab.github.io/dataMelanoma/reference/zhang2022_Stem.Sig.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Zhang 2022 Stem.Sig gene signature — zhang2022_Stem.Sig","text":"character vector 454 gene names, identified via single cell analysis 34 scRNA-seq datasets.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/zhang2022_test.html","id":null,"dir":"Reference","previous_headings":"","what":"Zhang 2022 test bulk RNAseq data — zhang2022_test","title":"Zhang 2022 test bulk RNAseq data — zhang2022_test","text":"Test data Zhang2022, post ComBat() preprocessing. See also zhang2022.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/zhang2022_test.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Zhang 2022 test bulk RNAseq data — zhang2022_test","text":"","code":"zhang2022_test"},{"path":"https://ggrlab.github.io/dataMelanoma/reference/zhang2022_test.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Zhang 2022 test bulk RNAseq data — zhang2022_test","text":"tibble 149 rows 15904 columns. columns, first 8 phenodata per sample (rows): batch, ID, OS, status, PFS, status2, response BOR. remaining columns gene expression data.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/zhang2022_training.html","id":null,"dir":"Reference","previous_headings":"","what":"Zhang 2022 training bulk RNAseq data — zhang2022_training","title":"Zhang 2022 training bulk RNAseq data — zhang2022_training","text":"Training data Zhang2022, post ComBat() preprocessing. See also zhang2022.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/zhang2022_training.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Zhang 2022 training bulk RNAseq data — zhang2022_training","text":"","code":"zhang2022_training"},{"path":"https://ggrlab.github.io/dataMelanoma/reference/zhang2022_training.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Zhang 2022 training bulk RNAseq data — zhang2022_training","text":"tibble 618 rows 15904 columns. columns, first 8 phenodata per sample (rows): batch, ID, OS, status, PFS, status2, response BOR. remaining columns gene expression data.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/zhang2022_validation.html","id":null,"dir":"Reference","previous_headings":"","what":"Zhang 2022 validation bulk RNAseq data — zhang2022_validation","title":"Zhang 2022 validation bulk RNAseq data — zhang2022_validation","text":"Validation data Zhang2022, post ComBat() preprocessing. See also zhang2022.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/reference/zhang2022_validation.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Zhang 2022 validation bulk RNAseq data — zhang2022_validation","text":"","code":"zhang2022_validation"},{"path":"https://ggrlab.github.io/dataMelanoma/reference/zhang2022_validation.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Zhang 2022 validation bulk RNAseq data — zhang2022_validation","text":"tibble 154 rows 15904 columns. columns, first 8 phenodata per sample (rows): batch, ID, OS, status, PFS, status2, response BOR. remaining columns gene expression data.","code":""},{"path":"https://ggrlab.github.io/dataMelanoma/news/index.html","id":"datamelanoma-v0009001","dir":"Changelog","previous_headings":"","what":"dataMelanoma v0.0.0.9001","title":"dataMelanoma v0.0.0.9001","text":"Added: create_data_project()","code":""}]
